13F filer · CIK 354204 ↗
Dimensional Fund Advisors LP
You are looking at Q3 2018. See the latest, Q2 2026 →
Reported value
$262.71B
+4.7% on the quarter before
Positions
3,425
134 new · 75 sold out
Top 10
9.6%
of the value
Est. gain
+$9.51B
on stocks held all quarter
Est. return
+3.9%
on those stocks since Q2 2018
Positions as of Sep 30, 2018, from Dimensional Fund Advisors LP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 16% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2018. Striped tiles are options.
Largest buys
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Avanos Med Inc~$213.7MNew · 0.0% → 0.1%+3,119,334 shares
- Broadcom~$148.0MAdded · 0.1% → 0.1%+599,685 shares
- Bausch Health Cos Inc~$135.5MNew · 0.0% → 0.1%+5,280,029 shares
- Strategic Ed Inc~$115.3MNew · 0.0% → 0.0%+841,722 shares
- Fedex Corp~$114.2MAdded · 0.1% → 0.2%+474,354 shares
- Prologis~$108.7MAdded · 0.2% → 0.2%+1,603,625 shares
- Berkshire Hathaway Inc Del~$92.0MAdded · 0.6% → 0.7%+429,745 shares
- Cigna Corporation~$91.6MAdded · 0.1% → 0.2%+440,063 shares
- United Technologies Corp~$88.9MAdded · 0.2% → 0.2%+635,869 shares
- Marriott Vacations Wrldwde C~$86.5MAdded · 0.1% → 0.1%+774,107 shares
Largest sells
Since Q2 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Jpmorgan Chase & Co~$424.8MCut · 1.1% → 1.0%−3,764,496 shares
- Cisco~$311.1MCut · 0.6% → 0.5%−6,393,953 shares
- Halyard Health Inc~$185.9MSold out · 0.1% → 0.0%−3,246,700 shares
- Wells Fargo Co New~$172.0MCut · 1.0% → 0.8%−3,272,069 shares
- Ggp Inc~$171.8MSold out · 0.1% → 0.0%−8,409,295 shares
- Ilg Inc~$163.9MSold out · 0.1% → 0.0%−4,962,788 shares
- Rsp Permian Inc~$153.3MSold out · 0.1% → 0.0%−3,483,324 shares
- Xl Group Ltd~$143.5MSold out · 0.1% → 0.0%−2,564,373 shares
- Validus Holdings Ltd~$133.1MSold out · 0.1% → 0.0%−1,969,601 shares
- Bank Amer Corp~$132.7MCut · 0.7% → 0.7%−4,505,351 shares
Holdings
As of Sep 30, 2018. Changes are in shares against Jun 30, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −0.09% · price +21.9% | 1.4% | $3.68B | +$661.4M | ||||||||
| Exxon Mobil CorpCOM · shares +1.5% · price +2.8% | 1.0% | $2.73B | +$72.7M | ||||||||
| AT&TCOM · shares −3.4% · price +4.6% | 1.0% | $2.68B | +$117.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −14% · price +8.3% | 0.97% | $2.56B | +$196.0M | ||||||||
| AmazonCOM · shares −0.5% · price +17.8% | 0.92% | $2.42B | +$367.0M | ||||||||
| MicrosoftCOM · shares −0.2% · price +16.0% | 0.92% | $2.42B | +$333.1M | ||||||||
| IntelCOM · shares −0.8% · price −4.9% | 0.92% | $2.41B | −$124.0M | ||||||||
| Pfizer IncCOM · shares −1.7% · price +21.5% | 0.89% | $2.35B | +$415.4M | ||||||||
| Wells Fargo Co NewCOM · shares −7.6% · price −5.2% | 0.80% | $2.09B | −$114.1M | ||||||||
| Comcast Corp NewCLA · shares −0.1% · price +7.9% | 0.72% | $1.89B | +$138.4M | ||||||||
| Bank Amer CorpCOM · shares −7.1% · price +4.5% | 0.67% | $1.75B | +$75.3M | ||||||||
| Berkshire Hathaway Inc DelCLB · shares +5.6% · price +14.7% | 0.66% | $1.74B | +$211.8M | ||||||||
| Chevron Corp NewCOM · shares −1.2% · price −3.3% | 0.61% | $1.60B | −$54.1M | ||||||||
| CiscoCOM · shares −18% · price +13.1% | 0.55% | $1.44B | +$166.8M | ||||||||
| Walmart IncCOM · shares −2.5% · price +9.6% | 0.50% | $1.31B | +$114.8M | ||||||||
| Citigroup IncCOM · shares +2.1% · price +7.2% | 0.47% | $1.23B | +$81.1M | ||||||||
| Johnson & JohnsonCOM · shares +1.1% · price +13.9% | 0.42% | $1.10B | +$131.9M | ||||||||
| Verizon Communications IncCOM · shares +3.0% · price +6.1% | 0.36% | $941.8M | +$52.7M | ||||||||
| American TowerCOM · shares +6.3% · price +0.8% | 0.35% | $931.9M | +$6.8M | ||||||||
| Bp PlcADR · shares −3.2% · price +1.0% | 0.35% | $908.1M | +$8.7M | ||||||||
| MetaCLA · shares +1.5% · price −15.4% | 0.33% | $860.9M | −$153.9M | ||||||||
| Medtronic PlcCLA · shares −2.2% · price +14.9% | 0.33% | $854.4M | +$110.7M | ||||||||
| Cvs Health CorpCOM · shares −0.8% · price +22.3% | 0.32% | $846.2M | +$154.4M | ||||||||
| Unitedhealth Group IncCOM · shares +0.5% · price +8.4% | 0.32% | $839.9M | +$65.0M | ||||||||
| Simon Ppty Group Inc NewCOM · shares +0.6% · price +3.9% | 0.31% | $817.6M | +$30.2M | ||||||||
| Total · 3,425 positions | 100% | $262.71B | +$9.51B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2018 to Q3 2018: 3,291 stocks held throughout, up $9.51B (+3.9%).
- Apple+$661.4M+22%
- Pfizer Inc+$415.4M+21%
- Amazon+$367.0M+18%
- Microsoft+$333.1M+16%
- Berkshire Hathaway Inc Del+$211.8M+15%
- General Mtrs Co−$85.4M−15%
- Micron−$97.1M−14%
- Wells Fargo Co New−$114.1M−5%
- Intel−$124.0M−5%
- Meta−$153.9M−15%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | $551.84B+15% | SEC ↗ |
| Q1 2026 | May 7, 2026 | $481.39B+1% | SEC ↗ |
| Q4 2025 | Feb 12, 2026 | $476.72B+2% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $466.01B+8% | SEC ↗ |
| Q2 2025 | Aug 12, 2025 | $431.92B+7% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $402.31B−3% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $416.38B+1% | SEC ↗ |
| Q3 2024 | Nov 7, 2024 | $412.28B+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $382.85B+4% | SEC ↗ |
| Q1 2024 | May 10, 2024 | $369.36B+8% | SEC ↗ |
| Q4 2023 | Feb 7, 2024 | $342.47B+12% | SEC ↗ |
| Q3 2023 | Nov 9, 2023 | $304.90B−3% | SEC ↗ |
| Q2 2023 | Aug 9, 2023 | $313.77B+6% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $296.87B−12% | SEC ↗ |
| Q4 2022 | Feb 9, 2023 | $338.47B+30% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $260.47B−7% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $278.78B−14% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $324.62B−2% | SEC ↗ |
| Q4 2021 | Feb 9, 2022 | $330.75B+7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $310.45B−2% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $315.84B+4% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $302.34B+9% | SEC ↗ |
| Q4 2020 | Mar 8, 2021 (amended) | $276.93B+17% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $235.82B+4% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $227.51B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $191.95B−30% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $274.39B+7% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $257.34B−0% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $257.55B+3% | SEC ↗ |
| Q1 2019 | Aug 12, 2019 (amended) | $251.08B+14% | SEC ↗ |
| Q4 2018 | Feb 26, 2019 (amended) | $220.75B−16% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $262.71B+5% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $250.84B+5% | SEC ↗ |
| Q1 2018 | May 11, 2018 | $239.94B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $241.23B+5% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $228.83B+6% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $216.59B+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $209.23B+5% | SEC ↗ |
| Q4 2016 | Feb 9, 2017 | $200.21B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $185.01B+6% | SEC ↗ |
| Q2 2016 | Aug 9, 2016 | $173.79B+4% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $167.06B | SEC ↗ |